Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare ... ( SOUTH SAN FRANCISCO Calif. Jan. 2...)

Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference

Date:1/24/2008

SOUTH SAN FRANCISCO, Calif., Jan. 24 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that George A. Scangos, Ph.D., president and chief executive officer of Exelixis, will present at the 2008 Wachovia Healthcare Conference at 9:30 a.m. ET / 6:30 a.m. PT on Thursday, January 31, 2008.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Brazil Bioethanol M...//www.reportlinker.com/p0165503/Brazil-Bioethanol-...Brazil Bioethanol Market Analysis and Forecasts to...tailed analysis and forecasts of the global bioeth...

(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...

(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...

(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmace...rk Office (PTO) has allowed the patent application...logy. , NOD technology is a highly effici...nto bio-adhesive nano-particles to enable oral del...s. NOD technology is a platform technology,that ca...

[0] Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 [0] French Ambassador for International Investment to Visit Chicago December 9 and 10 [0] deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal [0] US Patent Allowed for NOD Tech

...dingBlocks is market,s first service for pre-purch..., Dec. 9 The Scientific business of Thomson Reute... source for online access to industry codes and st... BuildingBlocks utility, allowing engineers to pre...hers such as ASTM (American Society for Testing a...

...H SAN FRANCISCO, Calif., Dec. 9 Proteolix, Inc. t...g that the company,s lead,product, carfilzomib, ha...nses,in patients with relapsed and refractory mult...lass of specific proteasome inhibitors being devel... malignancies and solid tumors. , Sundar Jag...

...TO, Calif., Dec. 9 BioMarin Pharmaceutical,Inc. (...Merck Serono, a division,of Merck KGaA, Darmstadt,...n(R) (sapropterin dihydrochloride) for the treatme...ia (PKU) or BH4 deficient patients,from the Europe...are,approximately 35,000 patients diagnosed with h...

Other Biology Technology:Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers 2 Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 2 Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 3 Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 4 Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 5 Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 6 Kuvan Receives Marketing Approval in the European Union 2 Kuvan Receives Marketing Approval in the European Union 3 Kuvan Receives Marketing Approval in the European Union 4

Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology Kuvan Receives Marketing Approval in the European Union

(Date:11/24/2009)...arctica has long held secrets of the earth,s histo...here has been very little information on the envir... for millions of years. Now, a team of researchers...funded to the tune of $10 million dollars by the N...bottom of things literally. These scientists will...

(Date:11/24/2009)...vember 24, 2009) New research on bacterial commun... reveals predictable temporal patterns, suggesting...rkers for monitoring climate change in the polar r...ceedings of the National Academy of Sciences Earl... six rivers shifted synchronously over time, corre...

(Date:11/23/2009)...arch presents strong evidence that the "synergisti...raffic-related pollution and indoor endotoxin caus...ther exposure alone. , Environmental health sc...ege of Medicine have shown that children exposed t...d indoor endotoxin during early life are six times...

Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2 Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2 Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2 Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1 Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2 As Good As a Deli For the Price of Making It At Home 52824 1 As Good As a Deli For the Price of Making It At Home 52824 2 Molecule plays early role in nonsmoking lung cancer 52821 1 Molecule plays early role in nonsmoking lung cancer 52821 2

[0] LSU gets to the bottom of things -- in Antarctica [0] Researchers establish common seasonal pattern among bacterial communities in Arctic rivers [0] Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later

...that interfere with the action of one particular e...roblems led scientists at Johns Hopkins to create ...w them to see multiple, real-time chemical reacti...ublished July 21 in the journal ACS Chemical Biolo...est chemicals on enzymes isolated from their norma...

...enetic material intact, scientists at Johns Hopkin... vital to managing a yeast cell,s energy. They dis...l of one of them led the cell to turn off 70 perce...ely unprepared for such a dramatic event," says Je...ology and genetics at Hopkins and author of the st...

...ads of Earthlings, arrays of single-cell creatures...le devices are riding on the International Space S...nd the University of New Mexico, NASA and US Air F...ons were directed by yeast and other single cells ... even in the vacuum and radiation of outer space -...

Other Biology News:Hopkins researchers develop new tool to watch real-time chemical activity in cells 2 Hopkins researchers develop new tool to watch real-time chemical activity in cells 3 Johns hopkins researchers find link between cell's energy use and genome health 2 Johns hopkins researchers find link between cell's energy use and genome health 3 Sandia work launched on space shuttle shows live cells influence growth of nanostructures 2 Sandia work launched on space shuttle shows live cells influence growth of nanostructures 3 Sandia work launched on space shuttle shows live cells influence growth of nanostructures 4 Sandia work launched on space shuttle shows live cells influence growth of nanostructures 5

Hopkins researchers develop new tool to watch real-time chemical activity in cells Johns hopkins researchers find link between cell's energy use and genome health Sandia work launched on space shuttle shows live cells influence growth of nanostructures

Mouse Anti-Human MYO7A Monoclonal Antibody, Unconjugated, Clone 1D3 from Abnova Corporation

..., Functionally-Validated, Ion Channel Cell Lines ...l role in nerve and muscle function and consequent... Drugs that modulate ion channels have been invest...ain, cardiac arrhythmia, hypertension, local anaes...

Mouse Anti-Human TTC3 Monoclonal Antibody, Unconjugated, Clone 2D10 from Abnova Corporation

Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation

Biology Products:

Mouse Anti-Human MYO7A Monoclonal Antibody, Unconjugated, Clone 1D3 from Abnova Corporation hERG-CHO K1 Recombinant Cell Line from Upstate Mouse Anti-Human TTC3 Monoclonal Antibody, Unconjugated, Clone 2D10 from Abnova Corporation Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation

Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare ...( SOUTH SAN FRANCISCO Calif. Jan. 2...)